Jain PharmaBiotech, Feb 2012, Pages: 481
Impact of antiretroviral treatment on transmission of HIV
Postexposure prophylaxis against HIV
Limitations of current therapies
Adverse effects of antiretroviral therapy
Drug resistance in AIDS
Effect
Frost & Sullivan, June 2009, Pages: 63
. Technology Assessment
- 2.1 Technology and Applications Viewpoint
- - 2.1 a Evolution of HIV Diagnostics
- - 2.1 b Competitive Landscape for HIV Diagnostics
- 2.2 Technology-Related Drivers, Restraints
Elsevier Science and Technology, June 2008, Pages: 560
virus evolution
- Retrovirus evolution and pathogenesis
- HIV population dynamics and drug treatments
- The impact of rapid evolution of hepatitis viruses
- Evolution of animal and human influenza viruses
Jain PharmaBiotech, Feb 2012, Pages: 780
for specific therapeutic areas described in the report. Examples of this are genotyping for drug resistance in HIV infection, personalized therapy of cancer, antipsychotics for schizophrenia, antidepressant
Jain PharmaBiotech, Feb 2012, Pages: 1029
Genotyping for drug-resistance in HIV
Neonatal screening of infants of HIV-positive mothers
Phenotyping as predictor of drug susceptibility/resistance in HIV
Point-of-care testing for HIV
Resolution
Jain PharmaBiotech, Feb 2012, Pages: 299
in copy number in the human genome
Structural variations in the human genome
Transposons
Retrotransposon capture sequencing
Mapping and sequencing of structural variation from human genomes
Impact
John Wiley and Sons Ltd, Aug 2007, Pages: 747
parts. The first is an introductory section looking at current infectious threats such as HIV/AIDS and malaria. The next part addresses evolution of pathogens and the relationship between human genetic
Global Industry Analysts, Inc., April 2011, Pages: 402
on Enquire before buying The Indian biotechnology industry was adversely affected by the global economic downturn, and the resultant impact on the foreign exchange rate. There was a significant slowdown
Global Industry Analysts, Inc., Jan 2011, Pages: 448
the Umbrella" 10
Evolution of New & Virulent Infectious Agents 11
The Enlightened Consumer of the 21st Century 11
Informa Healthcare, Jan 2001, Pages: 328
Details the evolution of HIV protease inhibitors from molecular development through medical applications!
Considering the latest class of revolutionary drugs fighting against HIV infection and AIDS
